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ABSTRACT
Introduction: Fatty liver is a multi-factorial gastrointestinal disorder that can lead to different 
disease and finally death. It is mostly silent without any obvious symptoms. This study is designed 
to determine the prevalence fatty liver after cadaver autopsy in 102 cadaver and its correlation 
with associated risk factors. Method: Liver autopsy was done on 102 cadaver refereeing to the 
legal medicine ward of Kerman on 2013. Clinical information and pathologic findings were 
recorded in statistical checklist. Finally data were analyzed with fisher’s exact test and mann-
whitney U statistical test in SPSS environment ver.20. Results: Mean of age was 43.25 ± 4.25 
Pathologic findings showed 18(17.64) fatty liver. None of risk factors showed a significant 
relation with the prevalence of fatty liver (P>0.05). Conclusion: According to the finding 
and based on similar scientific evidences fatty liver in this study has higher prevalence rate in 
compared with other studies and more detailed study with larger sample sizes is recommended 
for more accurate findings.
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INTRODUCTION
Non-alcoholic fatty liver disease (NAFLD) is known as the 
most prevalent cause of chronic liver disease in most parts of 
the world (1-3). NAFLD is histologically similar to alcohol-
ic liver disease, however, is not related to alcohol consump-
tion and is found to be one the frequent hepatic disorders. 
Patients are in a wide range regarding liver involvement. 
A large number of patients have a simple lipid accumulation 
in liver cells. A more severe form of this disorder is called 
non-alcoholic steatohepatitis which is known as a part of 
NAFLDes range (4).
Non-alcoholic fatty liver can lead to cirrhosis and hepatic 
failure (5). Appearance of these changes has been observed in 
different conditions such as obesity and hyperlipidemia (5,6), 
adult diabetes (7), and abetalipoproteinemia (5,7,8) as well 
as taking some medicines including amiodarone, glucocor-
ticoids, synthetic estrogens, insulin, chloroquine, tamox-
ifen (8). Histological appearance of NAFLD ranges from 
lipid accumulation in NAFLD hepatocytes, with no inflam-
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mation or fibrosis (simple hepatic steatosis) to hepatic ste-
atosis with one inflammatory-necrotic part (steatohepatitis) 
accompanied by fibrosis or not (9).
Liver biopsy is regarded as the gold standard for diagno-
sis of NAFLD. End-stage NAFLD patients should be consid-
ered for liver transplant. On the other hand, with increased 
prevalence of this disease in Iran, it has become one of the 
main reasons of liver transplant in the country.
In the present study, we tried to investigate the prevalence 
of NAFLD in the corpses at the autopsy hall of Kerman Fo-
rensic Medicine Center, 2011 as a limited study population 
in order to provide appropriate diagnostic and therapeutic 
strategies by epidemiological information obtained in this 
study.
METHOD
This was cross-sectional study that conducted on all corpses 
referred to Forensic Medicine Center in 2011, Kerman, Iran 
province.
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This study was confirmed in Ethics Committee of Ker-
man University of Medical Sciences. All data collected in 
this study were considered as confidential and were only 
generally reported.
A checklist was designed by the researchers to collect the 
required data through the deceased records as well as autopsy, 
pathology, and toxicology reports. In case of incomplete in-
formation, data were gathered with the help of their relatives. 
Data used in this study included age, gender, height, weight, 
body mass index (BMI), and the deceased education as demo-
graphic variables. Also the history of addiction, drug use, hy-
perlipidemia, cardiovascular diseases, hepatic and metabolic 
diseases, and abdominal pain were recorded for each person.
Statistical Analysis
The data were analyzed by SPSS where quantitative data 
were reported as mean and SD and qualitative ones as fre-
quency and percentage. Chi-square was used for comparison 
of qualitative variables and independent t-test for quantita-
tive data. The significance level was considered as 0.05.
RESULTS
In this study, totally 103 corpses (87 males) were investi-
gated. Mean±SDage and BMI were, respectively, 43.32 ± 
16.75 years and 24.48 ± 4.88 kg/m2. The investigated corpses 
did not show any history of alcohol consumption, hyperlip-
idemia, hepatic diseases, diabetes, and right upper quadrant 
tenderness. Among all corpses, 63 cases (61.2%) had been 
self-employed, 24 (23.3%) unemployed, and 16 (15.5%) la-
bor. According to toxicology findings, in 41 cases (39.8%) 
no toxic substances were found, while 46 cases (44.7%) 
were reported with methadone, codeine, and morphine tox-
icity, 14 cases (13.6%) with caffeine, and 2 cases of toxicity 
(1.9%) with other toxic substances.
The causes of death in the study corpses were listed as fol-
lows: 41 cases (39.8%) of drug overdose, 20 (19.4%) cardiac 
ischemic diseases, 16 (15.5%) internal diseases, 13 (12.6%) 
pneumonia, and 13 (12.6%) suicide. Table 1 indicates the 
frequency of other cases as the cause of death (Table 1).
Comparing mean age, height, and weight of the corpses 
with a history of abnormal liver enzymes, only their age was 
significantly lower than other cases (P = 0.03), no consid-
erable difference was observed in other factors. In contrast, 
BMI was significantly higher in the corpses with a history 
of abnormal liver enzymes compared with other corpses 
(28.78 ± 8.39 vs. 23.74 ± 3.70; P = 0.00). No meaningful 
association was found between gender and the status of liver 
enzymes (Table 2)
Comparing the frequency distribution of other variables 
in corpses with increased liver enzymes with other corpses, 
no significant difference was reported except for the case of 
cardiac diseases, BMI >25 kg/m2, and fatty liver (Table 3).
DISCUSSION
In the time of study, 103 corpses were referred to Kerman Fo-
rensic Medicine Center and investigated in the time of study. 
Table 1. Clinical histories of the study corpses 
N (%)
Education
Illiterate 30 (29.1)
Primary and high school 39 (37.9)
Diploma 27 (26.2)
Higher education 7 (6.8)
Use of Morphine
Yes 31 (30.1)
No 72 (69.9)
Cigarette smoking
Yes 31 (30.1)
No 72 (69.9)
Use of corticosteroid
Yes 1 (1)
No 102 (99)
Cardiovascular diseases
Yes 10 (9.7)
No 93 (90.3)
Hypertension
Yes 4 (3.9)
No 99 (96.1)
Pathological findings of liver
Steatohepatitis 9 (8.7)
Chronic hepatitis 41 (39.8)
Fatty liver 14 (13.6)
Others 39 (37.9)
Atherosclerosis
Yes 25 (24.3)
No 78 (75.7)
Coronary artery disease
Yes 23 (22.3)
No 80 (77.7)
Myocardial infarction
Yes 3 (2.9)
No 100 (97.1)
Old myocardial infarction
Yes 9 (91.3)
No 94 (8.7)
Liver tests
Abnormal 14 (13.6)
Normal 87 (86.4)
Regarding cause of death, drug overdose had the highest 
frequency. The age of corpses with abnormal liver enzymes 
was significantly lower than others, while BMI was notably 
higher in these cases. Cardiac disease, BMI >25 kg/m2, and 
fatty liver were more observed in corpses with abnormal liv-
er enzymes compared with other corpses.
NAFLD is histologically similar to alcoholic liver dis-
ease, however, it is not relevant to alcohol consumption 
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and is known as a frequent liver disease (6). This disorder 
is likely to develop at any age and gender (10,11). Some 
medical cases and histories such as obesity (5), hyperlipid-
emia (5,10), adult diabetes (7), and use of some drugs such 
as amiodarone, glucocorticoids, synthetic estrogens, insulin, 
chloroquine, and tamoxifen (12) can increase the chance of 
NAFLD incidence. In this regard, various studies have con-
sidered central obesity, diabetes mellitus in adults, dyslip-
idemia, and metabolic syndrome as the main risk factors of 
NAFLD.
The investigated corpses did not show any history of 
alcohol consumption, hyperlipidemia, liver diseases, di-
abetes, and right upper quadrant tenderness. Differences 
in findings compared with the mentioned studies and not 
observing main risk factors in the study corpses could be 
due to small sample size and that the study was limited to 
one center, as well as defects and biases in data collection 
and medical histories. As confirmed in our study, patients 
with NAFLD are generally asymptomatic with a mild and 
fluctuating increase in their liver enzymes. In agreement 
with the results of our study, the most common laboratory 
disorder in these patients is a slight to average increase in 
aminotransferases which is two to five times above nor-
mal (13).
The present study was limited by small sample size and, 
and as a result, this cannot be an appropriate epidemiologi-
cal study for investigating the causes of alcoholic fatty liver. 
Therefore, multicenter studies are recommended to identify, 
record, and report the cases of NAFLD.
CONCLUSION
According to the results of this study, it can be concluded 
that fatty liver and its relevant pathological findings can be 
found in a majority of corpses. Regarding hidden nature of 
this disease until the development of pathological changes in 
liver which limits management and treatment of the patients, 
it seems that multicenter studies along with more accurate 
data collection could provide a complete and proper image 
of the status of this disease in the country corpses.
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Table 2. The results of liver tests in the study corpses by 
gender
Status of 
liver enzymes
Corpses 
gender
N (%) P value
Negative Positive Total
Male 75 (86.2) 11 (78.6) 86 (85.1) 0.46
Female 12 (13.8) 3 (21.4) 15 (14.9)
Total 87 (100) 14 (100) 101(100)
(Contd...)
Table 3. Liver enzymes disorders in the study corpses
N (%) P
Education
Illiterate 4 (28.6) 0.24
Primary and high school 6 (42.9)
Diploma 3 (21.4)
Higher education 1 (7.1)
Use of Morphine
Yes 7 (50) 0.72
No 7 (50)
Cigarette smoking
Yes 3 (21.4) 0.42
No 11 (78.6)
Use of corticosteroid
Yes 0 (0) 0.69
No 14 (100)
Cardiovascular diseases
Yes 4 (28.6) 0.01
No 10 (71.4)
Hypertension
Yes 1 (7.1) 0.51
No 13 (92.9)
Pathological findings of liver
Steatohepatitis 0 (0) 0.00
Chronic hepatitis 0 (100)
Fatty liver 14 (0)
Others 0 (0)
Atherosclerosis
Yes 4 (28.6) 0.65
No 10 (71.4)
Coronary artery disease
Yes 4 (28.6) 0.58
No 10 (71.4)
Myocardial infarction
Yes 1 (7.1) 0.32
No 13 (92.9)
Old myocardial infarction
Yes 1 (7.1) 0.82
Table 3. (Continued)
N (%) P
No 13 (92.9)
BMI>25
Yes 10 (83.3) <0.001
No 2 (16.7)
Non-alcoholic fatty liver disease in corpses 13
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